Clinical Lymphoma Myeloma & Leukemia
Article . 2022 . Peer-reviewed
License: Elsevier TDM
Data sources: Crossref
P-106: Overcoming IMiDs-resistance in multiple myeloma by targeting MAP4K2
Authors: Shirong Li; Jing Fu; Jun Yang; Huihui Ma; Rajshekar Chakraborty; Markus Mapara; Christophe Marcireau; +1 Authors
Shirong Li; Jing Fu; Jun Yang; Huihui Ma; Rajshekar Chakraborty; Markus Mapara; Christophe Marcireau; Suzanne Lentzsch;
P-106: Overcoming IMiDs-resistance in multiple myeloma by targeting MAP4K2
No summary information available
1 Research products, page 1 of 1
- 2021IsAmongTopNSimilarDocuments
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).0 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
citations
Citations provided by BIP!
This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
popularity
Popularity provided by BIP!
This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
0
Average
Average
Average
Fields of Science
Fields of Science
Related to Research communities
Cancer Research
